1. National Amyloidosis Referral Center, CEPARM, University Hospital Federal University of Rio de Janeiro Rio de Janeiro Brazil
2. Department of Neurology, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan
3. Pfizer Inc New York New York USA
4. Department of Medicine (Neurology and Rheumatology) Shinshu University School of Medicine Matsumoto Japan